Igene Biotechnology

Igene Biotechnology EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Igene Biotechnology (IGNE) as of Oct 31, 2026 is -20.47.

EV/FCF

-20.47

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Igene Biotechnology is 2009 -20.47 . EV/FCF (Enterprise Value to Free Cash Flow) of Igene Biotechnology was 2008 - . It decreases by % lower compared to the previous year.

The Igene Biotechnology EV/FCF history

The Igene Biotechnology EV/FCF history
YEAREV/FCFYoY
-20.47—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Igene Biotechnology Stock analysis

What does Igene Biotechnology do? Igene Biotechnology Inc is a global biotechnology company focused on researching, developing, and marketing innovative solutions in the fields of health, nutrition, and the environment. The company was founded in Taipei, Taiwan, in 2005 and has since built an impressive track record of scientifically-based products and services. The business model of Igene Biotechnology Inc is based on the belief that advanced biotechnological technologies are the key to addressing the complex challenges facing humanity in terms of health, nutrition, and the environment. The company has specialized expertise in genomic research, microbial cultivation, fermentation, biochemistry, and nanotechnology, on which advanced products and services are built. Igene Biotechnology Inc is divided into three business divisions, each operating in different markets: healthcare, disease prevention, and environmental solutions. Each business division offers a wide range of products and services tailored to the specific needs of these markets. In the healthcare sector, Igene Biotechnology Inc focuses on developing innovative dietary supplements and functional foods designed to maintain and improve health. The company has developed a wide range of products tailored to the different needs of people, from vitamins and minerals to probiotic supplements and high-quality omega-3 fatty acid preparations. All products are scientifically-based and manufactured under strict quality controls. In the field of disease prevention, Igene Biotechnology Inc also offers a wide range of products and services. This involves meeting the specific needs of people with various diseases. The company offers diagnostic services, among other things, to meet the demand for personalized medicine. Igene Biotechnology Inc also develops special dietary supplements and medications for the treatment of chronic diseases such as diabetes, arthritis, and cardiovascular diseases. In the field of environmental solutions, Igene Biotechnology Inc focuses on developing innovative technologies and products to solve environmental problems. The company uses its extensive knowledge in the areas of microorganisms, fermentation, and bioreactors to offer diverse solutions, from wastewater treatment to the production of bioenergy and biobased chemicals. Over the years, Igene Biotechnology Inc has developed a large number of products that have been successfully introduced worldwide. The product range includes dietary supplements, functional foods, diagnostic and therapeutic devices, as well as environmentally friendly chemicals and biofuels. The focus on customer needs and close collaboration with scientific and industrial partners have helped make Igene Biotechnology Inc a globally recognized and respected company. Overall, Igene Biotechnology Inc has established itself as a leading company in the field of biotechnological innovations. The company has achieved impressive success in recent years and continues to strive to develop innovative solutions and services that contribute to health, nutrition, and the environment. Igene Biotechnology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Igene Biotechnology stock

EV/FCF (Enterprise Value to Free Cash Flow) of Igene Biotechnology is -20.47 in 2009.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Igene Biotechnology since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Igene Biotechnology with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Igene Biotechnology

All Key Metrics — Igene Biotechnology